Stay updated on Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3. This update does not alter the study details or page content.
    Difference
    0.0%
    Check dated 2026-03-11T16:09:06.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added; the earlier notice about government funding status (v3.4.1) was removed.
    Difference
    0.3%
    Check dated 2026-02-11T05:50:52.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added a public notice about potential disruptions due to a lapse in government funding and the NIH Clinical Center's operating status, with a link to opm.gov. Updated the site revision to v3.4.1, replacing v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-04T05:34:53.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    This update adds a Show glossary option and updates footer/QC-related labels (including a new Revision: v3.4.0) and related wording, while removing the older QC-label phrasing and No FEAR Act data wording. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T03:54:48.000Z thumbnail image
  8. Check
    69 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.3 to v3.3.4—a minor backend change with no impact on study details or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T03:01:22.000Z thumbnail image
  9. Check
    90 days ago
    Change Detected
    Summary
    The study locations section is updated to include Indiana, Missouri, New Mexico, Ohio, Pennsylvania, and Virginia with a revision tag v3.3.3. The previous location listings and the HHS Vulnerability Disclosure link from the prior revision (v3.3.2) were removed.
    Difference
    0.6%
    Check dated 2025-12-23T17:17:15.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial page.